Image created with AI Introduction Not long ago, artificial intelligence (“AI”) was a concept brought to life by human actors – whether through Scarlett Johansson’s voice in Her (2013) or as Alicia Vikander’s eerie humanoid presence in Ex Machina (2014). Today, the roles have reversed: it is AI that is creating on-screen performances that appear … Read more
Image created with AI I. Introduction Not long ago, artificial intelligence (“AI”) was a concept brought to life by human actors – whether through Scarlett Johansson’s voice in Her (2013) or as Alicia Vikander’s eerie humanoid presence in Ex Machina (2014). Today, the roles have reversed: it is AI that is creating on-screen performances that … Read more
By M. Marin NASDAQ:ORMP READ THE FULL ORMP RESEARCH REPORT Planning Phase 3 Oral Insulin study under revised protocol, new CRO agreement in place Oramed Pharmaceuticals (NASDAQ:ORMP) has pivoted its clinical R&D focus to prioritize studying ORMD 0801 for subpopulations of patients with pooled specific parameters who responded well to oral insulin in its prior … Read more
This guest post was authored by Dr Mukarrum Ahmed, Barrister (Lincoln’s Inn), and Lecturer in Business Law & Director of PG Admissions at Lancaster University Law School. I am most grateful to Dr Ahmed for complementing my earlier post on the CJEU case discussed, Joined Cases C‑345/22 and C‑347/22 Maersk. According to the doctrine of … Read more
Brown, Goldstein & Levy accomplice Greg Care was lately interviewed by Bloomberg Regulation on how states have been navigating laws after a federal decide’s ruling blocked the US Federal Commerce Fee’s nationwide ban on non-compete agreements. As an employment lawyer working with purchasers within the healthcare discipline, Greg has been monitoring the standing of non-compete … Read more